Electrical Stimulation Devices Market Forecast and Growth 2031

The electrical stimulation devices market size was estimated to be US$ 6.69 billion in 2021 and US$ XX billion in 2023 and is expected to reach US$ 16.27 billion by 2031. It is estimated to record a CAGR of 9.3% till 2031. Rising prevalence of neurological diseases, rising prevalence of chronic diseases and wearable electrical stimulation devices are likely to remain key electrical stimulation devices market trends.

Electrical Stimulation Devices Market Analysis

Chronic pain is a comples and debilitating pain condition that affects millions of people worldwide. The pain is defines that last more than 12 weeks, and persists for month or even year. Some of the common cause of chronic pain are injury, trauma, arthritis, nerve damage including others. Such pain also affects the daily socio and economic lives of patients. Growing prevalence of chronic pain is expected to device the growth of the market. As per centre of diseases control and prevention, during 2021, an estimated 20.9% of US adults experienced chronic pain, which was same as reported estimate of 20.4% in 2016. Chronic pain conditions mainly include the pain of back, knees, and arms, as well as other musculoskeletal conditions. Electrical stimulation devices have capability to reducing the pain to considerable extent. These benefits of electrical stimulation devices, coupled with increasing prevalence of chronic pain, drives the growth of the electrical stimulation devices market.

Electrical Stimulation Devices Market Overview

The growth of the market is attributed to some key driving factors such as rising prevalence of neurological diseases & chronic pain. However, high treatment cost of the devices is likely to show negative impact on market growth during the forecast period. Global electrical stimulation devices market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. The largest market for the electrical stimulation devices is held by the North American region. The factors that are influencing the market growth include rising research and development activities, growing financial investments by market players, and growing adoption of electrical stimulation devices within public and private organizations and within market players.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Electrical Stimulation Devices Market: Strategic Insights

Market Size Value in	US$ 5,643.7Million in 2019
Market Size Value by	US$ 11,334.0 Million by 2027
Growth rate	CAGR of 9.3% from 2020-2027
Forecast Period	2020-2027
Base Year	2020

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Electrical Stimulation Devices Market Drivers and Opportunities

Rising Prevalence of Neurological Diseases Favor the Electrical Stimulation Devices Market

Neurological diseases represent substantial burden on health systems in terms of disease identification, treatment, and management. Several frequently observed neurological diseases comprises narcolepsy, Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, spinal muscular atrophy (SMA), Duchenne muscular dystrophy, and others. A major new study released by The Lancet Neurology shows that, in 2021, more than 3 billion people worldwide were living with a neurological condition. Over the past few decades, there have been various research and development activities pertaining to the diagnosis and management of neurological diseases. Advancements in healthcare systems and modernizing diagnostic systems are likely to enhance the screening processes for rare neurological diseases. Such advancements, coupled with growing prevalence of neurological diseases, are driving the growth of the electrical stimulation devices market.

Growing Number of FDA Approvals and Product Launches – An Opportunity in the Electrical Stimulation Devices Market

Companies in the electrical stimulation devices market are undertaking increasing number of research and development activities to introduce more innovative products. The new electrical stimulation devices are equipped with advanced therapeutic platforms that can facilitate more effective pain relief. Further, substantially growing adoption of electrical stimulation devices is also leading to new product introductions. For instance, in Jan 2024 FDA approves Medtronic’s rechargeable deep brain stimulator for Parkinson’s, dystonia, essential tremors  and other health condition like OCS and epilepsy.  Furthermore in March 2023, Neuro20 Technologies Corp, a wearable medical device manufacturing company announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s 510(k) pre-market approval application for its Neuro20 PRO System. Thus, increasing adoption rate followed by product launch is seen to positively impact the electrical stimulation devices market, as it has an opportunity for medical device manufacturers.

Electrical Stimulation Devices Market Report Segmentation Analysis

Key segments that contributed to the derivation of the electrical stimulation devices market analysis are device type, application, and end user.

• Based on device type, the electrical stimulation device market is divided into Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electrical Stimulation (GES) Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Other Devices. The Spinal Cord Stimulation Devices segment held the largest share of the market in 2023; whereas the sacral nerve stimulation (SNS) devices segment is anticipated to register the highest CAGR % in the market during the forecast period.
• By application, the market is segmented into Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism and GIT Management, Incontinence Management, Other Application. The Pain Management segment held the largest share of the market in 2023; also, the segment is expected to register the highest CAGR in the market during 2023–2031.

Electrical Stimulation Devices Market Share Analysis by Geography

The geographic scope of the electrical stimulation device market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.  North America has dominated the electrical stimulation devices market. In North America, the US holds the significant share of the electrical stimulation devices market. The growth of the market in the country is primarily driven by increasing adoption of electrical stimulation devices, substantial prevalence of chronic pain, and product laucg in the local market. For instance Zynex, Inc. an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced that it has received clearance from the U.S. Food and Drug Administration ("FDA") for the next generation M-Wave Neuromuscular Electrical Stimulation ("NMES") device.

Electrical Stimulation Devices Market Report Scope

Electrical Stimulation Devices Market News and Recent Developments

The electrical stimulation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for electrical stimulation devices and strategies:

• Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter SCS Systems for the treatment of chronic low back and leg pain in people without prior back surgery, commonly referred to as non-surgical back pain (NSBP). (Source: Boston Scientific Corporation, Press Release, 2024)
• Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator (SCS) Systems for the treatment of painful diabetic peripheral neuropathy (DPN), a complication of diabetes that can affect the lower extremities of the body. Source: (Boston Scientific Corporation, Press Release, 2023)

Electrical Stimulation Devices Market Report Coverage and Deliverables

The “Electrical Stimulation Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles